Taiho Oncology is a Princeton-based specialty oncology company dedicated to improving cancer patients’ lives through the development and commercialization of orally administered anti-cancer agents. Its robust pipeline includes small-molecule candidates for both solid tumors and hematologic malignancies, with additional programs in preclinical development. As a subsidiary of Taiho Pharmaceutical Co., Ltd., part of Otsuka Holdings, Taiho Oncology leverages global expertise and resources to accelerate clinical progress. The company’s focus on oral therapeutics and its integrated North American, European, and Canadian operations distinguish it as a nimble, patient-centric player in the oncology landscape.
Taiho Oncology is seeking a Medical Director, Medical Affairs to build and implement the Medical Launch readiness plan for early pipeline products. The ideal candidate will have strategic and scientific expertise, strong business acumen, and medical affairs launch experience. The position involves leading the development of the Integrated Medical Affairs Plan (iMAP) and executing on medical affairs tactics, as well as working cross-functionally with other key functions at Taiho.
Taiho Oncology is a Princeton-based specialty oncology company dedicated to improving cancer patients’ lives through the development and commercialization of orally administered anti-cancer agents. Its robust pipeline includes small-molecule candidates for both solid tumors and hematologic malignancies, with additional programs in preclinical development. As a subsidiary of Taiho Pharmaceutical Co., Ltd., part of Otsuka Holdings, Taiho Oncology leverages global expertise and resources to accelerate clinical progress. The company’s focus on oral therapeutics and its integrated North American, European, and Canadian operations distinguish it as a nimble, patient-centric player in the oncology landscape.